(Reuters) -Obesity treatment developer Kailera Therapeutics said on Tuesday it had raised $400 million in a funding round.
Investment firms Atlas Venture, Bain Capital Life Sciences and RTW Investments co-led the round. Lyra Capital also participated, Kailera said.
The company is developing several injectable and oral therapies for weight management, it said.
(Reporting by Niket Nishant in Bengaluru; Editing by Shilpi Majumdar)
